Abstract
Bacterial biofilms on medical devices are a primary source of infection, and efforts have been made to develop means of decontaminating colonized devices including hemodialysis catheter “lock” solutions. Because bacterial biofilms are inherently resistant to many antibiotics and widespread use of antibiotics contributes to resistance development, there is a need for new approaches to biofilm eradication. We have developed a class of compounds, termed ceragenins, that mimic the antimicrobial activities of antimicrobial peptides. The ceragenins are active against established biofilms. We tested solutions of a lead ceragenin, CSA-13, with and without EGTA against biofilms comprised of Gram-negative and positive organisms. Similar solutions containing ciprofloxacin were used as comparators. The ceragenin solutions eradicated biofilms at concentrations comparable to those required for eradication by ciprofloxacin. However, against a methicillin- resistant strain of Staphylococcus aureus, CSA-13 proved to be far superior to ciprofloxacin.
Anti-Infective Agents in Medicinal Chemistry
Title: Activities of Ceragenin CSA-13 Against Established Biofilms in an In Vitro Model of Catheter Decolonization
Volume: 8 Issue: 4
Author(s): Jacob Pollard, Jon Wright, Yanshu Feng, Dianliang Geng, Carl Genberg and Paul B. Savage
Affiliation:
Abstract: Bacterial biofilms on medical devices are a primary source of infection, and efforts have been made to develop means of decontaminating colonized devices including hemodialysis catheter “lock” solutions. Because bacterial biofilms are inherently resistant to many antibiotics and widespread use of antibiotics contributes to resistance development, there is a need for new approaches to biofilm eradication. We have developed a class of compounds, termed ceragenins, that mimic the antimicrobial activities of antimicrobial peptides. The ceragenins are active against established biofilms. We tested solutions of a lead ceragenin, CSA-13, with and without EGTA against biofilms comprised of Gram-negative and positive organisms. Similar solutions containing ciprofloxacin were used as comparators. The ceragenin solutions eradicated biofilms at concentrations comparable to those required for eradication by ciprofloxacin. However, against a methicillin- resistant strain of Staphylococcus aureus, CSA-13 proved to be far superior to ciprofloxacin.
Export Options
About this article
Cite this article as:
Pollard Jacob, Wright Jon, Feng Yanshu, Geng Dianliang, Genberg Carl and Savage B. Paul, Activities of Ceragenin CSA-13 Against Established Biofilms in an In Vitro Model of Catheter Decolonization, Anti-Infective Agents in Medicinal Chemistry 2009; 8 (4) . https://dx.doi.org/10.2174/187152109789760225
DOI https://dx.doi.org/10.2174/187152109789760225 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Microenvironmental Determinants of Adult Neural Stem Cell Proliferation and Lineage Commitment in the Healthy and Injured Central Nervous System
Current Stem Cell Research & Therapy Recent Clinical Evidence in Bisphosphonate-related Osteomyelitis of the Jaw: Focus on Risk, Prevention and Treatment
Reviews on Recent Clinical Trials Proliferative Effect of FadA Recombinant Protein from <i>Fusobacterium nucleatum</i> on SW480 Colorectal Cancer Cell Line
Infectious Disorders - Drug Targets Emerging Anti-inflammatory Therapies for Atherosclerosis
Current Pharmaceutical Design Advances of Mesenchymal Stem Cells Derived from Bone Marrow and Dental Tissue in Craniofacial Tissue Engineering
Current Stem Cell Research & Therapy Proresolution Mediators and Receptors: Novel Drug Targets for Enhancing Pharmacological Armamentarium against Periodontal Inflammation
Infectious Disorders - Drug Targets Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Expression, Regulation and Function of Asporin, A Susceptibility Gene in Common Bone and Joint Diseases
Current Medicinal Chemistry Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three- Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile Delivery by Drug-Loaded Matrix Tablets
Current Pharmaceutical Design Pharmaceutical Lozenges: Recent Trends and Developments with an Update on Research and Patents
Recent Advances in Drug Delivery and Formulation Excessive Matrix Metalloproteinase Activity in Diabetes: Inhibition by Tetracycline Analogues with Zinc Reactivity
Current Medicinal Chemistry Patent Selections:
Current Biomarkers (Discontinued) Ofloxacin Loaded Electrospun Fibers for Ocular Drug Delivery: Effect of Formulation Variables on Fiber Morphology and Drug Release
Current Drug Delivery MicroRNA in Implant Dentistry: From Basic Science to Clinical Application
MicroRNA Matrix Metalloproteinases and Colon Anastomosis Repair: A New Indication for Pharmacological Inhibition?
Mini-Reviews in Medicinal Chemistry How Do Periodontal Infections Affect the Onset and Progression of Alzheimer’s Disease?
CNS & Neurological Disorders - Drug Targets Pharmacotherapies to Manage Bone Loss-Associated Diseases: A Quest for the Perfect Benefit-to-Risk Ratio
Current Medicinal Chemistry Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Anti-Cancer Agents in Medicinal Chemistry Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship
Current Diabetes Reviews Vitamins and Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets